Shuttle Pharmaceuticals Holdings, Inc.(SHPH)

Drug Manufacturers - Specialty & Generic · Gaithersburg, MD

$4.11+0.10 (+2.49%)

Delayed quote: Oct 6, 2026, 2:15 PM EDT

EV/EBITDA Ratio: N/A

Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/EBITDA ratio is N/A as of 2026-10-06T18:22:53.231Z.

Stored calculation inputs

Calculation as of: 2026-10-06T18:22:53.231Z.

Quote observation: 2026-10-06T18:15:02.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 2,404,880
Total debt · period ending 2026-06-30: 195,158
Cash · period ending 2026-06-30: 90,238
TTM operating EBITDA · period ending 2026-06-30: -9,032,333

FMP input reference: ef632b76806419539d367682e283305f5302e219c84c42b2c880863f64fefb48

EV/Sales|P/E Ratio|EBITDA|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

SHPH EV/EBITDA Ratio Metrics

EV/EBITDA RATIO

N/A

SHPH Competitors' EV/EBITDA Ratio

SHPH

Shuttle Pharmaceuticals Holdings, Inc.

Current

Market Cap

$2.40M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ONCO

Onconetix, Inc.

vs SHPH

Market Cap

$2.39M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MBRX

Moleculin Biotech, Inc.

vs SHPH

Market Cap

$2.37M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CELZ

Creative Medical Technology Holdings, Inc.

vs SHPH

Market Cap

$2.31M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

JAGX

Jaguar Health, Inc.

vs SHPH

Market Cap

$2.47M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

FBLG

FibroBiologics, Inc. Common Stock

vs SHPH

Market Cap

$2.49M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BIAF

bioAffinity Technologies, Inc.

vs SHPH

Market Cap

$2.55M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NUWE

Nuwellis, Inc.

vs SHPH

Market Cap

$2.62M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

VVOS

Vivos Therapeutics, Inc.

vs SHPH

Market Cap

$2.17M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

GOVX

GeoVax Labs, Inc.

vs SHPH

Market Cap

$2.17M

EV/EBITDA Ratio

N/A

TTM Avg

10388992794.84x

3Y Avg

12435877641.77x

5Y Avg

12435877641.77x

NAME	MARKET CAP	EV/EBITDA RATIO	TTM	3Y	5Y
Shuttle Pharmaceuticals Holdings, Inc. (SHPH)	$2.40M	N/A	N/A	N/A	N/A
Onconetix, Inc. (ONCO)vs ›	$2.39M	N/A	N/A	N/A	N/A
Moleculin Biotech, Inc. (MBRX)vs ›	$2.37M	N/A	N/A	N/A	N/A
Creative Medical Technology Holdings, Inc. (CELZ)vs ›	$2.31M	N/A	N/A	N/A	N/A
Jaguar Health, Inc. (JAGX)vs ›	$2.47M	N/A	N/A	N/A	N/A
FibroBiologics, Inc. Common Stock (FBLG)vs ›	$2.49M	N/A	N/A	N/A	N/A
bioAffinity Technologies, Inc. (BIAF)vs ›	$2.55M	N/A	N/A	N/A	N/A
Nuwellis, Inc. (NUWE)vs ›	$2.62M	N/A	N/A	N/A	N/A
Vivos Therapeutics, Inc. (VVOS)vs ›	$2.17M	N/A	N/A	N/A	N/A
GeoVax Labs, Inc. (GOVX)vs ›	$2.17M	N/A	10388992794.84x	12435877641.77x	12435877641.77x

EV/EBITDA Ratio Formula & Definition

EV/EBITDA = Enterprise Value / EBITDA (TTM)

Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Related Metrics

EV/Sales P/E Ratio EBITDA All Metrics